Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00198198 · ClinicalTrials.gov registry record · Phase 4
Aripiprazole Treatment of Bipolar Depression
A Phase 4 study of Bipolar Depression, sponsored by Indiana University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00198198: Completed Phase 4 study of Bipolar Depression, sponsored by Indiana University School of Medicine.
NCT00198198 is a Phase 4 study of Bipolar Depression that has completed, run by Indiana University School of Medicine. The registered enrollment target is 10 participants, below the 216-participant average among 29 other Bipolar Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00198198, a Phase 4 study of Bipolar Depression, has completed, sponsored by Indiana University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study of addition of aripirazole to the treatment of bipolar depressed patients who are not better on the medications that they are currently receiving.
Conditions Studied
Interventions
- DRUG Aripiprazole
Study Locations (1)
Indiana
- UH 3124 University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-08 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
What the finished NCT00198198 record still lists
NCT00198198 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 216-participant average among 29 other Bipolar Depression trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Bipolar Depression appearing as the primary indexed condition, and to 1 intervention - of which Aripiprazole is the first listed.
NCT00198198 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00198198 about?
NCT00198198 is a clinical study titled "Aripiprazole Treatment of Bipolar Depression". This is a study of addition of aripirazole to the treatment of bipolar depressed patients who are not better on the medications that they are currently receiving.
What is the current status of trial NCT00198198?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2005-08. Estimated completion is 2006-11.
What conditions does trial NCT00198198 study?
This clinical trial studies the following conditions: Bipolar Depression.
What interventions are being tested in trial NCT00198198?
The interventions under investigation include: Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00198198?
This trial is sponsored by Indiana University School of Medicine, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00198198 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00198198's enrollment target sits among peer trials
10 29th of 29 the lowest of 29 other Bipolar Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bipolar Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
RECRUITING · Phase 4
-
Minocycline for Bipolar Depression
COMPLETED · Phase 4
-
Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
RECRUITING · Early Phase 1
-
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
RECRUITING · Phase 3
-
University of Iowa Interventional Psychiatry Service Patient Registry
RECRUITING
-
Ketogenic Intervention for Bipolar Depression
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia